Potential Target Therapy Market Overview

The report is titled as ‘Potential Target Therapy Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the potential target therapy market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Potential target therapy market is expected to grow with significant rate in the near future.

The global potential target therapy market in 2019 is accounted for more than US$ xx Bn and expected to reach at a value of US$ XX Bn by 2028 with a significant CAGR of x.x%.

Potential Target Therapy Market Dynamics

Rising prevalence of cancer disease is increasing the need for effective therapy to treat them which is the major factor driving the growth of the potential target therapy. For instance, according to National Institute of Cancer in 2019, the number of new cases of cancer (cancer incidence) is 439.2 per 100,000 men and women per year (based on 2011–2015 cases). The number of cancer deaths is 163.5 per 100,000 people per year.

In addition, various government policies and initiatives to provide fund for research and development is also boosting the growth of the target market. Furthermore, having less side-effect as compared to conventional treatments is preferred by patients, thus propelling the growth of the potential market as they have very few side effects.

Moreover, with the increase in demand of precision medicine which uses information about a person’s genes and proteins to prevent, diagnose, and treat disease is also increasing the growth of the potential target therapy market. However, high cost for target therapy is restraining the growth of the target market. Additionally, difficulty in their production and development is likely to hamper the growth of potential market in the near future.

Potential Target Therapy Market Segmentation

Potential target therapy market is segmented on the basis of drug type, application, distribution channel, and by region.

•    By Drug Type:

    Monoclonal Antibody Therapeutics

    Protein/Peptide Therapeutics

    Small Molecule Drugs

    RNA Interference

    Stem Cell Therapy

    Gene Therapy

•    By Application

    Immunology

    Oncology

    Infectious Diseases

    Others

•    By Distribution Channel

    Drug Stores

    Retail Pharmacies 

    Hospital Pharmacies

    Online Sales

•    By Region

    North America

    Europe

    Asia Pacific

    Latin America

    Middle East

    Africa

Potential Target Therapy Market Overview

In the potential target therapy, targeted therapy is a cancer treatment that uses drugs. Targeted therapy targets cancer’s specific genes, proteins, as well as tissue environment that contributes to the growth of cancer. It helps in the treatment of breast cancer, lung cancer, leukaemia, melanoma, and other type of cancer. There are various target therapeutics which are approved by Food and Drug Administration for the treatment of cancer.

Source: National Institute of Cancer, 2019

Potential Target Therapy Market Competitive Landscape

Some of the key participating players in potential target therapy market are Bind Therapeutics, Boehringer Ingelheim, Bristol Mayer Squibb, Celldex Therapeutics, Dendreon Corporation, Eli Lily, GalaxoSmithKline, Galena Biopharma, ImmunoCellular Therapeutics, and Inovio Pharmaceuticals.

Regional Segmentation

On the basis of region, the potential target therapy market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.

MMC Overview on Potential Target Therapy Market Report

The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

A research report on the Potential Target Therapy market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth include (but not restricted to):

•    New product designs and launches

•    Current product compliance

•    Reimbursement

•    Concerns for use of Potential Target Therapy

•    Advantages of Potential Target Therapy 

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.

1.    Global Potential Target Therapy Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Potential Target Therapy Market Overview

2.1.    Introduction

2.1.1.    Market Definition

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Potential Target Therapy Market Snapshot

2.4.    Global Potential Target Therapy Market Size and Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Potential Target Therapy Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Key Regulations

2.7.    Porter’s Five Forces Model

3.    Global Potential Target Therapy Market, By Drug Type

3.1.    Introduction

3.1.1.    Annual Growth Rate Comparison, By Drug Type

3.1.2.    BPS Analysis, By Drug Type

3.2.    Market Revenue (US$Mn) Forecast, By Drug Type

3.2.1.    Monoclonal Antibody Therapeutics

3.2.2.    Protein/Peptide Therapeutics

3.2.3.    Small Molecule Drugs

3.2.4.    RNA Interference

3.2.5.    Stem Cell Therapy

3.2.6.    Gene Therapy

3.3.    Global Potential Target Therapy Market Attractiveness Index, By Drug Type

4.    Global Potential Target Therapy Market, By Application

4.1.    Introduction

4.1.1.    Annual Growth Rate Comparison, By Application

4.1.2.    BPS Analysis, By Application

4.2.    Market Revenue (US$Mn) Forecast, By Application

4.2.1.    Immunology

4.2.2.    Oncology

4.2.3.    Infectious Diseases

4.2.4.    Others

4.3.    Global Potential Target Therapy Market Attractiveness Index, By Application

5.    Global Potential Target Therapy Market, By Distribution Channel

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Distribution Channel

5.1.2.    BPS Analysis, By Distribution Channel

5.2.    Market Revenue (US$Mn) Forecast, By Distribution Channel

5.2.1.    Drug Stores

5.2.2.    Retail Pharmacies 

5.2.3.    Hospital Pharmacies

5.2.4.    Online Sales

5.3.    Global Potential Target Therapy Market Attractiveness Index, By Distribution Channel

6.    Global Potential Target Therapy Market, By Region

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Region

6.1.2.    BPS Analysis, By Region

6.2.    Market Revenue (US$Mn) Forecast, By Region

6.2.1.    North America

6.2.2.    Latin America

6.2.3.    Europe

6.2.4.    Asia Pacific

6.2.5.    Middle East

6.2.6.    Africa

6.3.    Global Potential Target Therapy Market Attractiveness Index, By Region

7.    North America Potential Target Therapy Market Analysis and Forecast, 2020–2028

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Country

7.1.2.    BPS Analysis, By Country

7.2.    Market Revenue (US$Mn) Forecast, By Country

7.2.1.    U.S. Potential Target Therapy Market

7.2.2.    Canada Potential Target Therapy Market

7.3.    North America Potential Target Therapy Market, By Drug Type

7.3.1.    Monoclonal Antibody Therapeutics

7.3.2.    Protein/Peptide Therapeutics

7.3.3.    Small Molecule Drugs

7.3.4.    RNA Interference

7.3.5.    Stem Cell Therapy

7.3.6.    Gene Therapy

7.4.    North America Potential Target Therapy Market, By Application

7.4.1.    Immunology

7.4.2.    Oncology

7.4.3.    Infectious Diseases

7.4.4.    Others

7.5.    North America Potential Target Therapy Market, By Distribution Channel

7.5.1.    Drug Stores

7.5.2.    Retail Pharmacies 

7.5.3.    Hospital Pharmacies

7.5.4.    Online Sales

7.6.    North America Potential Target Therapy Market Attractiveness Index

7.6.1.    By Country

7.6.2.    By Drug Type

7.6.3.    By Application

7.6.4.    By Distribution Channel

8.    Latin America Potential Target Therapy Market Analysis and Forecast, 2020–2028

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market (US$Mn) Forecast, By Country

8.2.1.    Brazil Potential Target Therapy Market

8.2.2.    Mexico Potential Target Therapy Market

8.2.3.    Argentina Potential Target Therapy Market

8.2.4.    Rest of Latin America Potential Target Therapy Market

8.3.    Latin America Potential Target Therapy Market, By Drug Type

8.3.1.    Monoclonal Antibody Therapeutics

8.3.2.    Protein/Peptide Therapeutics

8.3.3.    Small Molecule Drugs

8.3.4.    RNA Interference

8.3.5.    Stem Cell Therapy

8.3.6.    Gene Therapy

8.4.    Latin America Potential Target Therapy Market, By Application

8.4.1.    Immunology

8.4.2.    Oncology

8.4.3.    Infectious Diseases

8.4.4.    Others

8.5.    Latin America Potential Target Therapy Market, By Distribution Channel

8.5.1.    Drug Stores

8.5.2.    Retail Pharmacies 

8.5.3.    Hospital Pharmacies

8.5.4.    Online Sales

8.6.    Latin America Potential Target Therapy Market Attractiveness Index

8.6.1.    By Country

8.6.2.    By Drug Type

8.6.3.    By Application

8.6.4.    By Distribution Channel

9.    Europe Potential Target Therapy Market Analysis and Forecast, 2020–2028

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) Forecast, By Country

9.2.1.    U.K. Potential Target Therapy Market

9.2.2.    Germany Potential Target Therapy Market

9.2.3.    Italy Potential Target Therapy Market

9.2.4.    France Potential Target Therapy Market

9.2.5.    Spain Potential Target Therapy Market

9.2.6.    Russia Potential Target Therapy Market

9.2.7.    Poland Potential Target Therapy Market

9.2.8.    BENELUX Potential Target Therapy Market

9.2.9.    NORDIC Potential Target Therapy Market

9.2.10.    Rest of Europe Potential Target Therapy Market

9.3.    Europe Potential Target Therapy Market, By Drug Type

9.3.1.    Monoclonal Antibody Therapeutics

9.3.2.    Protein/Peptide Therapeutics

9.3.3.    Small Molecule Drugs

9.3.4.    RNA Interference

9.3.5.    Stem Cell Therapy

9.3.6.    Gene Therapy

9.4.    Europe Potential Target Therapy Market, By Application

9.4.1.    Immunology

9.4.2.    Oncology

9.4.3.    Infectious Diseases

9.4.4.    Others

9.5.    Europe Potential Target Therapy Market, By Distribution Channel

9.5.1.    Drug Stores

9.5.2.    Retail Pharmacies 

9.5.3.    Hospital Pharmacies

9.5.4.    Online Sales

9.6.    Europe Potential Target Therapy Market Attractiveness Index

9.6.1.    By Country

9.6.2.    By Drug Type

9.6.3.    By Application

9.6.4.    By Distribution Channel

10.    Asia Pacific Potential Target Therapy Market Analysis and Forecast, 2020–2028

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) Forecast, By Country

10.2.1.    China Potential Target Therapy Market

10.2.2.    India Potential Target Therapy Market

10.2.3.    Japan Potential Target Therapy Market

10.2.4.    Australia and New Zealand Potential Target Therapy Market

10.2.5.    South Korea Potential Target Therapy Market

10.2.6.    ASEAN Potential Target Therapy Market

10.2.7.    Rest of Asia Pacific Potential Target Therapy Market

10.3.    Asia Pacific Potential Target Therapy Market, By Drug Type

10.3.1.    Monoclonal Antibody Therapeutics

10.3.2.    Protein/Peptide Therapeutics

10.3.3.    Small Molecule Drugs

10.3.4.    RNA Interference

10.3.5.    Stem Cell Therapy

10.3.6.    Gene Therapy

10.4.    Asia Pacific Potential Target Therapy Market, By Application

10.4.1.    Immunology

10.4.2.    Oncology

10.4.3.    Infectious Diseases

10.4.4.    Others

10.5.    Asia Pacific Potential Target Therapy Market, By Distribution Channel

10.5.1.    Drug Stores

10.5.2.    Retail Pharmacies 

10.5.3.    Hospital Pharmacies

10.5.4.    Online Sales

10.6.    Asia Pacific Potential Target Therapy Market Attractiveness Index

10.6.1.    By Country

10.6.2.    By Drug Type

10.6.3.    By Application

10.6.4.    By Distribution Channel

11.    Middle East Potential Target Therapy Market, By Region

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$Mn) Forecast, By Country

11.2.1.    GCC Countries Potential Target Therapy Market

11.2.2.    Israel Potential Target Therapy Market

11.2.3.    Oman Potential Target Therapy Market

11.2.4.    Rest of Middle East Potential Target Therapy Market

11.3.    Middle East Potential Target Therapy Market, By Drug Type

11.3.1.    Monoclonal Antibody Therapeutics

11.3.2.    Protein/Peptide Therapeutics

11.3.3.    Small Molecule Drugs

11.3.4.    RNA Interference

11.3.5.    Stem Cell Therapy

11.3.6.    Gene Therapy

11.4.    Middle East Potential Target Therapy Market, By Application

11.4.1.    Immunology

11.4.2.    Oncology

11.4.3.    Infectious Diseases

11.4.4.    Others

11.5.    Middle East Potential Target Therapy Market, By Distribution Channel

11.5.1.    Drug Stores

11.5.2.    Retail Pharmacies 

11.5.3.    Hospital Pharmacies

11.5.4.    Online Sales

11.6.    Middle East Potential Target Therapy Market Attractiveness Index

11.6.1.    By Country

11.6.2.    By Drug Type

11.6.3.    By Application

11.6.4.    By Distribution Channel

12.    Africa Potential Target Therapy Market, By Region

12.1.    Introduction

12.1.1.    Annual Growth Rate Comparison, By Country

12.1.2.    BPS Analysis, By Country

12.2.    Market (US$Mn) Forecast, By Country

12.2.1.    South Africa Potential Target Therapy Market

12.2.2.    Egypt Potential Target Therapy Market

12.2.3.    North Africa Potential Target Therapy Market

12.2.4.    Rest of Africa Potential Target Therapy Market

12.3.    Africa Potential Target Therapy Market, By Drug Type

12.3.1.    Monoclonal Antibody Therapeutics

12.3.2.    Protein/Peptide Therapeutics

12.3.3.    Small Molecule Drugs

12.3.4.    RNA Interference

12.3.5.    Stem Cell Therapy

12.3.6.    Gene Therapy

12.4.    Africa Potential Target Therapy Market, By Application

12.4.1.    Immunology

12.4.2.    Oncology

12.4.3.    Infectious Diseases

12.4.4.    Others

12.5.    Africa Potential Target Therapy Market, By Distribution Channel

12.5.1.    Drug Stores

12.5.2.    Retail Pharmacies 

12.5.3.    Hospital Pharmacies

12.5.4.    Online Sales

12.6.    Africa Potential Target Therapy Market Attractiveness Index

12.6.1.    By Country

12.6.2.    By Drug Type

12.6.3.    By Application

12.6.4.    By Distribution Channel

13.    Recommendation

13.1.    Market Strategy

14.    Competitive Landscape

14.1.    Competition Dashboard

14.2.    List and Company Overview of Global Key Players

14.3.    Company Profiles

14.3.1.    Bind Therapeutics

14.3.1.1.    Company Overview

14.3.1.2.    Financial Overview

14.3.1.3.    Component Portfolio

14.3.1.4.    Key Developments

14.3.1.5.    Business Strategies

14.3.2.    Boehringer Ingelheim

14.3.3.    Bristol Mayer Squibb

14.3.4.    Celldex Therapeutics

14.3.5.    Dendreon Corporation

14.3.6.    Eli Lily

14.3.7.    GalaxoSmithKline

14.3.8.    Galena Biopharma

14.3.9.    ImmunoCellular Therapeutics

14.3.10.    Inovio Pharmaceuticals

15.    Acronyms